Anti- Hypertensive Medications

There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications. Drug treatment options are limited, as many antihypertensive may negatively affect the fetus. Methyldopa, hydralazine, and labetalol are most commonly used for severe pregnancy hypertension.

 Drug treatments are available too for Hypertension. Optimal blood pressure control plays an essential role in the therapeutic management of RVHT. However, aggressive control of other risk factors for atherosclerosis also is crucial. Cessation of smoking is important for its positive impact on the cardiovascular risk profile in patients with hypertension. Similarly, antidyslipidemic therapy for those patients with hyperlipidemia likely provides benefit in atherosclerotic RVHT.

  • Diuretics
  • Calcium channel blockers
  • ACE Inhibitors
  • Angiotensin II receptor antagonists
  • Vasodilators
  • Benzodiazepines

Related Conference of Anti- Hypertensive Medications

November 02-03, 2017

3rd Global Summit on Heart Diseases

Bangkok, Thailand
December 11-12, 2017

22nd World Cardiology Conference

Rome, Italy
February 19-21, 2018

23rd European Heart Disease and Heart Failure Congress

Paris, France
19-20 March ,2018

23rd World Cardiology Conference

Hong Kong
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
May 14-16, 2018

2nd World Heart Congress

Tokyo, Japan
June 11-13, 2018

24th Annual Cardiologists Conference

Barcelona, Spain
July 11-12, 2018

International Conference on Cardiovascular Imaging

Sydney,Australia
July 18-19, 2018

25th Annual Cardiology Conference

Atlanta, USA
September 10-12, 2018

4th International Conference on Hypertension & Healthcare

Zurich, Switzerland
September 17-19,2018

25th Annual Cardiologists Conference

Tin Shui Wai,Hong Kong
October 17-18, 2018

Global Cardiology Summit

Seoul, South Korea

Anti- Hypertensive Medications Conference Speakers

Recommended Sessions

Related Journals

Are you interested in